Format

Send to

Choose Destination
BMC Med Ethics. 2017 Feb 2;18(1):8. doi: 10.1186/s12910-016-0165-6.

Regulation of genomic and biobanking research in Africa: a content analysis of ethics guidelines, policies and procedures from 22 African countries.

Author information

1
Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. jantina.devries@uct.ac.za.
2
Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
3
Department of Clinical Pharmacology, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
4
Center for Health Promotion and Prevention Research, School of Public Health, University of Texas Health Science Center at Houston, Houston, USA.
5
Cameroon Bioethics Initiative (CAMBIN), Yaounde, Cameroon.
6
University of Stellenbosch, Stellenbosch, South Africa.
7
National Health Research Ethics Committee, Federal Ministry of Health, Abuja, Nigeria.
8
Navrongo Health Research Centre, Ghana Health Service, Navrongo, Ghana.

Abstract

BACKGROUND:

The introduction of genomics and biobanking methodologies to the African research context has also introduced novel ways of doing science, based on values of sharing and reuse of data and samples. This shift raises ethical challenges that need to be considered when research is reviewed by ethics committees, relating for instance to broad consent, the feedback of individual genetic findings, and regulation of secondary sample access and use. Yet existing ethics guidelines and regulations in Africa do not successfully regulate research based on sharing, causing confusion about what is allowed, where and when.

METHODS:

In order to understand better the ethics regulatory landscape around genomic research and biobanking, we conducted a comprehensive analysis of existing ethics guidelines, policies and other similar sources. We sourced 30 ethics regulatory documents from 22 African countries. We used software that assists with qualitative data analysis to conduct a thematic analysis of these documents.

RESULTS:

Surprisingly considering how contentious broad consent is in Africa, we found that most countries allow the use of this consent model, with its use banned in only three of the countries we investigated. In a likely response to fears about exploitation, the export of samples outside of the continent is strictly regulated, sometimes in conjunction with regulations around international collaboration. We also found that whilst an essential and critical component of ensuring ethical best practice in genomics research relates to the governance framework that accompanies sample and data sharing, this was most sparingly covered in the guidelines.

CONCLUSIONS:

There is a need for ethics guidelines in African countries to be adapted to the changing science policy landscape, which increasingly supports principles of openness, storage, sharing and secondary use. Current guidelines are not pertinent to the ethical challenges that such a new orientation raises, and therefore fail to provide accurate guidance to ethics committees and researchers.

PMID:
28153006
PMCID:
PMC5289015
DOI:
10.1186/s12910-016-0165-6
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center